MTXX: 5.96 +0.25 (4.38%) - Matrixx Initiatives, Inc.

MTXX: 5.96 +0.25 (4.38%) - Matrixx Initiatives, Inc.: "Net profit margin 10.19% 12.42%
Operating margin 16.14% 19.99%
EBITD margin - 21.26%
Return on average assets 13.71% 16.36%
Return on average equity 17.30% 20.00%
Employees 34"
1. Range 5.60 - 6.15
2. 52 week 4.39 - 19.74
3. Open 5.66
4. Vol / Avg. 1.02M/74,000.00
5. Mkt cap 56.36M
6. P/E 4.12
7. Div -
8. EPS 1.45
9. Shares 9.46M
10. Beta 0.47
11. Inst. own 79%

Matrixx Initiatives, Inc. develops, produces, markets and sells over-the-counter (OTC) healthcare products with an emphasis on those that utilize delivery systems that provide consumers with Better Ways to Get Better. Through its subsidiary, Zicam, LLC, the Company markets and sells products under the Zicam brand. The Company’s product offerings consist of four product classes within the cough and cold category: Cold Remedy; Allergy/Sinus; Cough and Multi-Symptom relief, and other cough/cold. In addition, the Company had sold products under the Nasal Comfort and Xcid brand names. Its Zicam products are marketed in the cough and cold market category. During the fiscal year ended March 31, 2009 (fiscal 2009), the Company’s top 15 customers accounted for more than 80% of its net sales and three customers each accounted for more than 10% of the Company’s net sales. In May 2008, the Company formed Zicam Canada, Inc. to commercialize sales of Zicam products in Canada.

www.stockcaps.blogspot.com